FDA Adverse Event Malfunction Summary report: N

RFTL

MDR report key: 20556646 · Received October 29, 2024

Report

Report Number
9611612-2024-00024
Event Type
Malfunction
Date Received
October 29, 2024
Date of Event
September 30, 2024
Report Date
November 14, 2024
Manufacturer
PAJUNK GMBH MEDIZINTECHNOLOGIE
Product Code
GXI
UDI-DI
04048223050187
PMA / PMN Number
K060397
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

EVENT TOOK PLACE IN BELGIUM. THIS PRODUCT ANALYSIS WAS CARRIED OUT ON THE BASIS OF ALL THE INFORMATION PROVIDED AND THE INTERNAL REVIEW AT PAJUNK. BASED ON ANALYSIS, RISK ASSESSMENT, RISK PROFILE AND CLINICAL MONITORINGTHIS FILE IS CONSIDERED AS CLOSED. IN CASE NEW INFORMATION BECOMES AVAILABLE A FOLLOW UP REPORT WILL BE SENT TO THE AGENCY.

Additional Manufacturer Narrative · 0

IRN# (B)(4). INITIAL BATCH REVIEW DOES NOT INDICATE ANY ADVERSE CONCLUSION. ALL PARAMETERS WITHIN SPECIFICATION.

Description of Event or Problem · 0

IRN# (B)(4). EVENT OCCURRED IN BELGIUM. TENTITIVE DESCRIPTION OF EVENT: SKIN BURNS DURING PROCEDURE.

Description of Event or Problem · 0

IRN# (B)(4). EVENT OCCURRED IN BELGIUM: TENTITIVE DESCRIPTION OF EVENT: SKIN BURNS DURING PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
303423 RFTL RFTL CANNULA/ PROBE, RADIOFREQUENCY LESION PRODUCT CODE: GXI GXI PAJUNK GMBH MEDIZINTECHNOLOGIE 001165-22C 1514 04048223050187

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other